Deloitte acquired substantially all of the assets of Gryphon Scientific, LLC, a Takoma Park, MD-based leader in biosafety, biosecurity, and all-hazards preparedness and response, with experience in using artificial intelligence (AI) to enhance security and safety.
The amount of the deal was not disclosed.
The acquisition will strengthen Deloitte team with a complement of data-driven biosecurity detection, prevention and emergency response solutions. Gryphon’s cadre of specialists will enhance Deloitte’s capability to address its clients’ most complex mission challenges, from informing safe policy and practice around novel technologies and AI to strengthening capacities to prevent, detect and respond to infectious disease threats across the globe.
Led by Dr. Rocco Casagrande, founder and executive chairman, Gryphon has supported senior decision makers within government and the commercial sector in evaluating emerging technologies and understanding how to enable the rapid development of these critical tools, while also safeguarding against their associated risks. Gryphon is at the forefront of AI safety, especially understanding how AI can change the risk landscape of biological and chemical threats.
Together, Gryphon and Deloitte leaders will continue to develop practical AI applications in health, encourage multi-sector collaboration, and identify and manage risks to create trustworthy AI solutions through the Federal Health AI Accelerator at Deloitte.
At Deloitte, Gryphon’s technical specialists will advance Deloitte’s life science and public health preparedness and response capabilities, catalyzing the growth of Deloitte’s biosecurity, lab safety, data science, and global and domestic emergency preparedness and response capabilities.
FinSMEs
29/04/2024